Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis.

American journal of respiratory and critical care medicine - 15 Oct 2005

Saiman Lisa, Mayer-Hamblett Nicole, Campbell Preston, Marshall Bruce C

Abstract excerpt

RATIONALE: We recently reported a randomized, placebo-controlled trial of azithromycin in patients with cystic fibrosis (CF) that demonstrated a 6.2% improvement in the 168-d relative change in FEV1 among azithromycin participants compared with placebo participants. OBJECTIVES: In the current analyses, heterogeneity of treatment response and the association between FEV1 and the risk of pulmonary exacerbations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azithromycin
Share to Deoxyribonuclease I

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Monitoring

Share to Forced Expiratory Volume

Share to Hospitalization

Share to Pneumonia, Bacterial

Share to Pseudomonas Infections

Share to Tobramycin

Source

Identifiers

PMID: 16040785
DOI: 10.1164/rccm.200502-218OC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis.PMID 16040785Read ↗

Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosisSemantic proximity Read ↗

The role of macrolides in asthma: current evidence and future directions.Semantic proximity Read ↗

Sputum bacterial load and bacterial composition correlate with lung function and are altered by long term azithromycin treatment in children with HIV-associated chronic lung diseaseSemantic proximity Read ↗

Steady-State Therapy with Azithromycin or Low-Dose Prednisolone in Paediatric Cystic Fibrosis Patients: Inflammatory Markers and Disease Progression.Semantic proximity Read ↗

Is there a role for macrolides in severe asthma?Semantic proximity Read ↗

Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.Semantic proximity Read ↗

Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD: A systematic review and meta-analysis of randomized trials and cohort studiesSemantic proximity Read ↗

Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data.Semantic proximity Read ↗

Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations.Semantic proximity Read ↗

Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.